Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist and hCG Triggering in Poor Ovarian Response
NCT02144818Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jan 2014
- Primary completion
- Jul 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of triptorelin and choriogonadotropin alfa in poor ovarian response (POR), sponsored by Sheba Medical Center. Primary endpoint: Number of mature oocytes at 12 months. Status: unknown.
02
Drugs
triptorelinchoriogonadotropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT02144818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144818.